Facioscapulohumeral MD, likely the most prevalent form of MD, currently has no cure, but several factors point to the potential for successful development of a diseas...

The UAE has rapidly transformed its healthcare sector in the past decade. Adhiti Sharad Kumar explains the UAE’s 2021 Vision, which states that the UAE will invest co...

Innovator companies have employed a variety of multipronged strategies to counter biosimilar competition. These include development of ‘biobetter’, gaining regulatory...

Although James Lind conducted the first controlled clinical trial back in 1747, it wasn’t until the Nuremberg Code in 1947 and the Declaration of Helsinki in 1964 tha...

The relatively low cost to enter the “generic” market and the size of the biologic drug market make entry attractive. However, the failure rate for biosimilars is dee...

From the perspective of a clinical trial, a rare disease suggests the available patient and site population is quite small and distributed diffusely. Likewise, any ch...

Bacteriophages are viruses that can be found inside plants and animals and in soil, rivers, oceans, and even sewers. Phages invade bacterial cells and inject their DN...

There has been considerable discussion around the concept of patientcentricity in the pharmaceutical community. The industry has taken a collective pause in an effort...

Where information overload has started to slow innovation and efficiency in medicinal markets, could artificial intelligence and machine learning help – by pinpointin...

The healthcare industry needs a fully connected IT infrastructure, integrating information from multiple systems to ease administrative workloads, facilitate patient-...